Global Influenza Vaccine Manufacturing Capacity: Analysis

Overview

Conducted analysis of global influenza vaccine manufacturing capacity and production technologies to assess the availability of seasonal and pandemic vaccines. This work examined current production capabilities and surge capacity to inform discussions on global vaccine supply and pandemic preparedness.

Role

Lead analyst and author of analysis examining global influenza vaccine manufacturing capacity and production technologies.

Key Contributions & Outputs

• Analysis of global influenza vaccine manufacturing capacity across major producers

• Assessment of production technologies and their implications for pandemic vaccine supply

• Evaluation of potential surge capacity for pandemic influenza vaccine production

• Identification of logistical, economic, and geographic constraints affecting global influenza vaccine availability

Published analysis: Global production capacity of seasonal and pandemic influenza vaccines in 2023

Impact

Findings informed discussions on global influenza vaccine supply and manufacturing capacity, including implications for vaccine access, equity, and pandemic preparedness.